Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network

PURPOSE: Approximately 1–2% of chronic myeloid leukemia (CML) patients harbor atypical BCR-ABL1 transcripts that cannot be monitored by real-time quantitative PCR (RT-qPCR) using standard methodologies. Within the European Treatment and Outcome Study (EUTOS) for CML we established and validated robu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Vivien, White, Helen E., Gerrard, Gareth, Möbius, Susanne, Saussele, Susanne, Franke, Georg-Nikolaus, Mahon, François-X., Talmaci, Rodica, Colomer, Dolors, Soverini, Simona, Machova Polakova, Katerina, Cross, Nicholas C. P., Hochhaus, Andreas, Ernst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397658/
https://www.ncbi.nlm.nih.gov/pubmed/33677711
http://dx.doi.org/10.1007/s00432-021-03569-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397658/
https://www.ncbi.nlm.nih.gov/pubmed/33677711
http://dx.doi.org/10.1007/s00432-021-03569-8

Ejemplares similares